Profil bibliographique

Farrukh T. Awan

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

458Publications signalées

9502Citations signalées

5Affiliations récentes

Les institutions déclarées

Southwestern Medical Center Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center The University of Texas Southwestern Medical Center Northeast Ohio Medical University

Les domaines associés

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentCAR-T cell therapy researchChronic Myeloid Leukemia TreatmentsImmunodeficiency and Autoimmune Disorders

Les publications récentes

Accès ouvert 2026 article OpenAlex

Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma

Farrukh T. Awan, Ran Liu, Hsin-Hui Huang, Matthew Bye et autres

us (code pays fourni par la source)

0 citations British Journal of Haematology

2026 conference-abstract OpenAlex

MCL-1551: Second Primary Malignancies After Mantle Cell Lymphoma: A Population-Based SEER Analysis of Cancer-Specific and Long-Term Risk

Muhammad Sarfaraz Khan, Shahzaib Maqbool, Arham Ihtesham, Waleed Dita et autres

gb, us, pk (code pays fourni par la source)

0 citations Clinical Lymphoma Myeloma & Leukemia

2026 article OpenAlex

ABCL-1559: Temporal Decline in Second Primary Malignancy Risk Among Patients With Diffuse Large B-Cell Lymphoma Across the Rituximab Early Adoption Era (2000–2005), Rituximab Standard Use Era (2006–2012), and Targeted Therapy Era (2013–2021): A Population-Based Analysis

Shahzaib Maqbool, Thea Danielle Amadasun, Mohammed Ebad Ur Rehman, Imran Khan et autres

us, gb (code pays fourni par la source)

0 citations Clinical Lymphoma Myeloma & Leukemia

2026 article OpenAlex

POSTER: MCL-1551: Second Primary Malignancies After Mantle Cell Lymphoma: A Population-Based SEER Analysis of Cancer-Specific and Long-Term Risk

Muhammad Sarfaraz Khan, Shahzaib Maqbool, Arham Ihtesham, Waleed Dita et autres

gb, us, pk (code pays fourni par la source)

0 citations Clinical Lymphoma Myeloma & Leukemia

2026 article OpenAlex

POSTER: ABCL-1584: Persistent Excess Risk of Second Primary Malignancies in Follicular Lymphoma Survivors: Site-Specific and Latency-Based Findings From SEER, 2000–2022

Muhammad Sarfaraz Khan, Shahzaib Maqbool, Arham Ihtesham, Waleed Dita et autres

gb, us, pk (code pays fourni par la source)

0 citations Clinical Lymphoma Myeloma & Leukemia

2026 article OpenAlex

ABCL-1584: Persistent Excess Risk of Second Primary Malignancies in Follicular Lymphoma Survivors: Site-Specific and Latency-Based Findings From SEER, 2000–2022

Muhammad Sarfaraz Khan, Shahzaib Maqbool, Arham Ihtesham, Waleed Dita et autres

gb, us, pk (code pays fourni par la source)

0 citations Clinical Lymphoma Myeloma & Leukemia

Accès ouvert 2026 article OpenAlex

Pharmacologic activity, safety, and preliminary efficacy of GEN3009, a CD37-targeting DuoHexaBody, in relapsed or refractory B-cell non-Hodgkin’s lymphoma

Farrukh T. Awan, Joshua T. Gamse, Marije B. Overdijk, Esther C W Breij et autres

us, nl, dk, es (code pays fourni par la source)

0 citations Journal for ImmunoTherapy of Cancer

Accès ouvert 2026 article OpenAlex

CD19 CAR T-cell therapy is feasible for patients with pemphigus vulgaris treated without lymphodepletion in the RESET-PV trial

Daniel Nunez, Jason Stadanlick, Thomas Furmanak, Jessica Goldenberg et autres

us, ph (code pays fourni par la source)

2 citations Blood

2026 conference-abstract OpenAlex

Late infectious complications after CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy for large B-cell lymphomas (LCBL): Real-world predictors and outcomes.

Daniel E. Goyco Vera, Omer Abdrabbuh, Fatima Massare Somers, Song Zhang et autres

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology

Accès ouvert 2026 article OpenAlex

Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma

Joseph P. McGuirk, Armin Ghobadi, Carlos Bachier, Paul Shaughnessy et autres

us, au, ch (code pays fourni par la source)

1 citation Blood Advances

Accès ouvert 2026 article OpenAlex

Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia

Richard R. Furman, William G. Wierda, Piers EM Patten, Jorge M. Chaves et autres

us, gb, it, ca (code pays fourni par la source)

1 citation Blood Advances

2026 review OpenAlex

26-A-19249-ACC MAJOR CARDIOVASCULAR EVENTS IN PATIENTS RECEIVING TUMOR-INFILTRATING LYMPHOCYTE THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF LATTER-PHASE TRIALS

Jean Kim, Mustafa Houmsse, Saad Badat, Benjamin Lee et autres

us (code pays fourni par la source)

0 citations Journal of the American College of Cardiology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.